November 19, 2012
Many of us who live with HIV are alive today in part because we received effective treatment to clear our hepatitis C (HCV) co-infections. Interferon-boosted Ribavirin was a lifesaver, but the interferon side effects could be rugged.
MedPage Today reports that a triple-drug regimen without interferon has been found in a small study to be highly effective in clearing even treatment-resistant HCV genotype 1. FDA approval for clinical use is still a long way off, but we look forward to a future of effective HCV treatment without interferon.
No comments have been made.
|What Would an HIV Cure Mean for You?|
|Condomless Anal Sex Rising in U.S. MSM With or Without HIV Infection|
|If We Act to Remove Structural, Behavioral and Social Barriers, We Can End the HIV Epidemic With the Medicines We Already Have|
|This Week in HIV Research: Immune System Differences Could Produce bNAbs; New HIV Infections Are No Longer Falling; and Zoledronic Acid May Prevent Bone Loss|
|What's the Next Game-Changer in HIV Treatment?|